Summary:
American Institute of Research is conducting a research study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus.
Qualified participants must:
1. Men or women at least 40 years old with a diagnosis of type 2 diabetes.
2. Established cardiovascular disease, including at least 1 of the following:
a. Coronary artery disease
- Documented history myocardial infarction
- Documented coronary artery disease (CAD)
- stent - coronary revascularization procedure.
- coronary artery bypass graft (CABG)).
b. Cerebrovascular disease – ANY of the following:
- Documented history of ischaemic stroke
Carotid arterial disease with 50% stenosis
- Carotid vascular procedure (e.g. stenting or surgical revascularization)
c. Peripheral arterial disease (PAD)
Qualified Participants May Receive:
free medical care for your diabetes as well as additional diabetes medication and $50.00 for each completed visit.